Carbohydrate antigen (CA) 19–9, CA72–4, and carcinoembryonic antigen have been the extensively adopted GC biomarkers, yet they are not the best diagnostic and prognostic biomarkers for GC because of the limited specificity or sensitivity [19, 20]. The gene discussed is CEACAM5; the disease is gastric cancer.